Request Legal Help Now - Free
LAWSUITS NEWS & LEGAL INFORMATION

Olmesartan Linked to Intestinal Problems

Were you looking for Benicar lawsuits?


Olmesartan has been linked to serious gastrointestinal side effects, including an increased risk of sprue-like enteropathy. Olmesartan (sold as Benicar, Benicar HCT, Azor, Tribenzor, and other generics) is used to treat high blood pressure, but the US Food and Drug Administration (FDA) has issued a warning about the risk of sprue-like enteropathy, a potentially serious condition that could require hospitalization. Attorneys are investigating possible olmesartan lawsuits alleging the makers of olmesartan products did not adequately warn about the risks.

FREE OLMESARTAN SIDE EFFECTS LAWSUIT EVALUATION

Send your Olmesartan Side Effects claim to a lawyer who will review your claim at NO COST or obligation.
GET LEGAL HELP NOW

Olmesartan (Benicar)

Olmesartan (Benicar) is in a group of drugs known as angiotensin II receptor blockers (ARBs), used to treat high blood pressure. So far, olmesartan drugs are the only to be linked to sprue-like enteropathy.

Products containing olmesartan include Benicar, Benicar HCT, Azor, Tribenzor and generic medications.

Olmesartan Sprue-Like Enteropathy

benicarcasepageOlmesartan (Benicar) products have been linked to an increased risk of sprue-like enteropathy. Sprue-like enteropathy is a potentially serious condition marked by chronic diarrhea, weight loss and colitis. Symptoms can take months or years to develop, but can require hospitalization. Some patients who developed sprue-like enteropathy have had symptoms improve after discontinuing use of olmesartan products.

A study published in Mayo Clinic Proceedings (August 2012) suggested a link between olmesartan (Benicar) and sprue-like enteropathy. Researchers found that of 22 patients seen at a hospital for unexplained chronic diarrhea and enteropathy while taking olmesartan, symptoms of 18 patients improved after they stopped taking the medication.

FDA Olmesartan Warning

On July 3, 2013, the FDA warned that use of olmesartan could cause sprue-like enteropathy. The FDA noted that it was evaluating the safety of the products, but said the announcement was made after data from the Adverse Event Reporting System showed "clear evidence of an association between olmesartan and sprue-like enteropathy." At the time, the FDA requested an update to the labels of olmesartan products to warn about the increased risk.

Legal Help

If you or a loved one has suffered similar damages or injuries, please click the link below and your complaint will be sent to a lawyer who may evaluate your claim at no cost or obligation.
Last updated on

OLMESARTAN SIDE EFFECTS LEGAL ARTICLES AND INTERVIEWS

Benicar Sprue-Like Enteropathy Continuing to Drive Litigation
Benicar Sprue-Like Enteropathy Continuing to Drive Litigation
March 22, 2015
Little Rock, AR While all medications have side effects, it’s evident that some side effects are more serious than others. In the case of Benicar side effects, a malady known as sprue-like enteropathy can trigger chronic diarrhea and other gastrointestinal ailments that have the potential to foster weight loss, dehydration and serious health issues going forward READ MORE

Benicar Sprue-Like Enteropathy More Than Just “Unpleasant”
Benicar Sprue-Like Enteropathy More Than Just “Unpleasant”
February 13, 2015
Washington, DC For the majority of Americans, diarrhea and dehydration are temporary annoyances that bring discomfort and inconvenience, but clear up once the gastrointestinal cause of these symptoms abates. However, for patients suffering Benicar side effects, such symptoms can be long lasting and can land many a Benicar patient in the hospital for an undetermined period of time READ MORE

ADD YOUR COMMENT ON THIS ISSUE

Fields marked * are mandatory. Please read our comment guidelines before posting.

*Name:

Note: Your name will be published with your comment.

*Email Address:

Your email will only be used if a response is needed.
*Your Comment:

Are you the defendant or a subject matter expert on this topic with an opposing viewpoint? We'd love to hear your comments here as well, or if you'd like to contact us for an interview please submit your details here.
Request Legal Help Now! - Free